Camber Pharma Launches Generic Urocit-K®

Piscataway, NJ, April 8, 2021– Camber Pharmaceuticals is pleased to announce that it has launched Potassium Citrate ER Tablets, which is the generic version of Urocit-K®
Potassium Citrate ER Tablets are used to treat a kidney stone condition called renal tubular acidosis.
Potassium Citrate ER Tablets are available from Camber in 5 mEq, 10mEq and 15 mEq – 100 count bottles.
Recent articles
- Camber Launches Eslicarbazepine Acetate Tablets
- Camber Launches Phenylephrine Hydrochloride Injection, USP
- Camber Launches Chlorzoxazone Tablets, USP
- Camber Launches 13 New Generic Products in Q1 2025, Sets Ambitious Pace for the Year
- Camber Launches Lurasidone Hydrochloride Tablets
- Camber Launches Mycophenolate Mofetil Capsules